| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NBIX, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 31 sales. Those positions are worth an estimated $3.9M at current prices.
Our model assigns Lyons Gary A a middling insider score of 54/100, based on 14 past trades. Over a 12-month horizon, 38.5% of those trades were profitable, with an average 12-month return of -4.9%.
Lyons Gary A's largest disclosed position is in TVTX as Director, worth about $3.9M. The recent filings there lean toward selling, a net 58,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE10b5-1 | 10,000 | $63.28 | $632,845.97 | -14.0% | - | - | |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE10b5-1 | 8,000 | $41.07 | $328,560.00 | -12.2% | +33.6% | - | |
| Dec 3, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 15,000 | $152.61 | $2,289,082.50 | -11.1% | -13.7% | - | |
| Oct 4, 2024 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE10b5-1 | 40,000 | $14.73 | $589,100.78 | -44.0% | +24.6% | +61.8% | |
| Aug 13, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 11,570 | $150.43 | $1,740,449.65 | -8.9% | -15.6% | -12.7% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 930 | $150.03 | $139,530.23 | -0.8% | -21.0% | -9.5% | |
| May 14, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 12,500 | $135.63 | $1,695,370.00 | -9.7% | +6.4% | -14.2% | |
| Dec 22, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sell10b5-1 | 10,000 | $130.04 | $1,300,443.00 | -4.9% | +11.9% | +5.4% | |
| Dec 1, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 5,000 | $116.77 | $583,837.00 | -2.4% | +11.3% | +8.2% | |
| Sep 12, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE10b5-1 | 5,000 | $115.02 | $575,120.00 | -2.4% | +1.2% | +3.7% |